Jim,
Well said, I agree , you are right on target with this one. BLUD's time has come. Especially now with the small cap market getting lots of attention and the biotech/healthcare sector looking good again to investors.
Re: 400 indications to buy the ABS...this is the coupon program BLUD ran to get an idea of how many OF THEIR CUSTOMERS were interested in buying an ABS. Remember, the 400 are already BLUD customers. The entire market for the ABS is closer to 2000 or more in the USA (3200 hospitals alone in USA, not counting independent labs and blood centers). With a GM of 40%, and a market price of $80 - 110, 000 , the profit potential is HUGE. Add to this the reagent trail you mentioned. Any take-over suitors will have to pay up for this company (30 - 40 per share minimum).
Also, the company has in effect at this time a stock buy back program to purchase up to 10% of the outstanding stock. It is not known how much, if any, stock BLUD has purchased. But any stock purchased by the company will decrease the float and increase EPS.
BLUD Brother,
Dominic |
